The National Heart, Lung, and Blood Institute (NHLBI) announced its Strategic Vision to chart the course of heart, lung, blood, and sleep research over the next 10 years.
After collaborating with various stakeholders, including the American Society of Hematology, and engaging more than 4,500 respondents from all 50 U.S. states, as well as 42 countries, the NHLBI outlined the following four main goals:
- understand human biology
- reduce human disease
- advance translational research
- develop workforce and resources
With innovations in areas such as computational biology, data science, bioengineering, and other technologies, NHLBI hopes that the initiative will provide more information on:
- the complex interplay of environmental, behavioral, and molecular factors that promote health
- the earliest point of disease development
- the ability to repair damaged hearts with stem cell and tissue engineering techniques
- a new generation of novel therapeutics
- the ability to develop cures through gene editing and stem cell technology for sickle cell disease and other conditions
Source: NHLBI press release, August 11, 2016.